Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020

Recently, Gao et al. published an article titled “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials” which concluded that monthly administration of fremanezumab led to significant reduction in monthly migraine...

Descripción completa

Detalles Bibliográficos
Autores principales: Barash, Steve, Ramirez Campos, Verena, Ning, Xiaoping, Driessen, Maurice T., Krasenbaum, Lynda J., Carr, Karen, Cohen, Joshua M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514361/
https://www.ncbi.nlm.nih.gov/pubmed/34581836
http://dx.doi.org/10.1007/s00210-021-02156-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514361/
https://www.ncbi.nlm.nih.gov/pubmed/34581836
http://dx.doi.org/10.1007/s00210-021-02156-5

Ejemplares similares